AKTS
Aktis Oncology, Inc.
22.90$
+0.7%
vs. previous close
Closing price · As of: Sep 17, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Aktis Oncology, Inc. (AKTS) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 08/13/2026 | Current report (8-K) | Aktis Oncology, Inc. (AKTS): Results of Operations and Financial Condition; Financial Statements and Exhibits | View report ↗ |
| 07/20/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
| 07/17/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
| 07/08/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
| 07/08/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.